Global Non-opioid Analgesic Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-opioid Analgesic Patch Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Non-opioid Analgesic Patch report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-opioid Analgesic Patch market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Online Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-opioid Analgesic Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Analgesic Patch key companies include GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan and Teh Seng Pharmaceutical Mfg, etc. GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd. are top 3 players and held % share in total in 2022.
Non-opioid Analgesic Patch can be divided into Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches and Capsaicin Patches, etc. Lidocaine Patches is the mainstream product in the market, accounting for % share globally in 2022.
Non-opioid Analgesic Patch is widely used in various fields, such as Hospital Pharmacies, Online Pharmacies and Independent Pharmacies & Drug Stores,, etc. Hospital Pharmacies provides greatest supports to the Non-opioid Analgesic Patch industry development. In 2022, global % share of Non-opioid Analgesic Patch went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Analgesic Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
GlaxoSmithKline Plc
Pfizer, Inc.
Teikoku Seiyaku Co., Ltd.
Mylan N.V.
Hisamitsu Pharmaceutical Co.,Inc
Acorda Therapeutics, Inc
Endo International plc
Allergan
Teh Seng Pharmaceutical Mfg
IBSA Institut Biochimque SA
Segment by Type
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-opioid Analgesic Patch market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Non-opioid Analgesic Patch introduction, etc. Non-opioid Analgesic Patch Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Non-opioid Analgesic Patch market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Non-opioid Analgesic Patch industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Analgesic Patch key companies include GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan and Teh Seng Pharmaceutical Mfg, etc. GlaxoSmithKline Plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd. are top 3 players and held % share in total in 2022.
Non-opioid Analgesic Patch can be divided into Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches and Capsaicin Patches, etc. Lidocaine Patches is the mainstream product in the market, accounting for % share globally in 2022.
Non-opioid Analgesic Patch is widely used in various fields, such as Hospital Pharmacies, Online Pharmacies and Independent Pharmacies & Drug Stores,, etc. Hospital Pharmacies provides greatest supports to the Non-opioid Analgesic Patch industry development. In 2022, global % share of Non-opioid Analgesic Patch went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Analgesic Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
GlaxoSmithKline Plc
Pfizer, Inc.
Teikoku Seiyaku Co., Ltd.
Mylan N.V.
Hisamitsu Pharmaceutical Co.,Inc
Acorda Therapeutics, Inc
Endo International plc
Allergan
Teh Seng Pharmaceutical Mfg
IBSA Institut Biochimque SA
Segment by Type
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
Segment by Application
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Non-opioid Analgesic Patch market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Non-opioid Analgesic Patch introduction, etc. Non-opioid Analgesic Patch Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Non-opioid Analgesic Patch market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.